GlaxoSmithKline Pharmaceuticals Limited
GLAXO (NSE)

1,547.95

26,151.21
Proj. ROE (%)
31.97
Proj. P/E (x)
-
Proj EV / EBITDA (x)
28.39
Proj. P/BV (x)
10.04
Proj. Revenue ( Cr.)
-

Stock View

HOLD
Share on
The average score for GlaxoSmithKline Pharmaceuticals Limited stands at 9 against 5, three months back.

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in the business of manufacturing, distributing, and trading in pharmaceuticals. It manufactures medicinal substances used in the manufacture of pharmaceuticals, such as antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts, and esters; glycosides and vegetable alkaloids, and chemically pure sugar. It offers a range of prescription medicines, vaccines, and consumer healthcare products. Its medicine portfolio includes Adartrel, Bactroban, Combodart, and Duodart. Its vaccines portfolio includes Ambirix, Cervarix, Fendrix, and Havrix. The Company’s products include Betamethasone, Potassium Clavulanate with Amoxycillin and Pneumococcal Polysaccharide and Conjugate Vaccine. Its oral health products include Sensodyne, parodontax and Polident. Its manufacturing unit is located at Nashik.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
1,523.57
100 DMA ()
1,550.72
200 DMA ()
1,592.52
52 Weeks Range
1,450.00
1,918.75
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity